UroGen Pharma Ltd Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | 08/14/2026 | 4.54 M | $167.22 M | 0.00% | 9.02% |
| BLACKROCK, INC. | 08/07/2026 | 3.20 M | $117.81 M | 12.51% | 6.35% |
| MORGAN STANLEY | 08/13/2026 | 2.58 M | $94.81 M | 0.64% | 5.11% |
| KYNAM CAPITAL MANAGEMENT, LP | 08/14/2026 | 2.43 M | $89.58 M | 8.31% | 4.83% |
| JEFFERIES FINANCIAL GROUP INC. | 08/17/2026 | 2.20 M | $80.95 M | 0.00% | 4.37% |
| SG AMERICAS SECURITIES, LLC | 08/07/2026 | 2.05 M | $75.55 M | 23.83% | 4.07% |
| AMERICAN CENTURY COMPANIES INC | 08/12/2026 | 1.69 M | $62.03 M | 2.94% | 3.35% |
| ACORN CAPITAL ADVISORS, LLC | 08/14/2026 | 1.67 M | $61.58 M | 0.00% | 3.32% |
| POINT72 ASSET MANAGEMENT, L.P. | 08/14/2026 | 1.53 M | $56.14 M | 100.00% | 3.03% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 08/14/2026 | 1.51 M | $55.51 M | 14.80% | 2.99% |
| OPALEYE MANAGEMENT INC. | 08/14/2026 | 1.44 M | $52.99 M | 0.70% | 2.86% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 08/13/2026 | 1.30 M | $47.91 M | -13.38% | 2.58% |
| MENORA MIVTACHIM HOLDINGS LTD. | 08/13/2026 | 1.15 M | $42.41 M | 0.00% | 2.29% |
| D. E. SHAW & CO., INC. | 08/14/2026 | 1.15 M | $42.17 M | 11.99% | 2.27% |
| STATE STREET CORP | 09/22/2026 | 1.00 M | $36.91 M | 14.74% | 1.99% |
| MPM BIOIMPACT LLC | 08/14/2026 | 933.42 K | $34.35 M | -1.10% | 1.85% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 08/11/2026 | 829.81 K | $30.54 M | 14.14% | 1.65% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 819.83 K | $30.17 M | 36.98% | 1.63% |
| MIGDAL INSURANCE & FINANCIAL HOLDINGS LTD. | 08/10/2026 | 770.91 K | $28.37 M | 0.00% | 1.53% |
| ORBIMED ADVISORS LLC | 08/14/2026 | 676.19 K | $24.88 M | -22.76% | 1.34% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 610.36 K | $22.46 M | 16.52% | 1.21% |
| WOODLINE PARTNERS LP | 08/14/2026 | 500.73 K | $18.43 M | 0.00% | 0.99% |
| BOXER CAPITAL MANAGEMENT, LLC | 08/14/2026 | 500.00 K | $18.40 M | 0.00% | 0.99% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 475.70 K | $17.51 M | 275.21% | 0.94% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 456.56 K | $16.80 M | 11.48% | 0.91% |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 08/13/2026 | 387.07 K | $14.24 M | 0.00% | 0.77% |
| NORTHERN TRUST CORP | 08/13/2026 | 304.57 K | $11.21 M | 10.38% | 0.60% |
| RICE HALL JAMES & ASSOCIATES, LLC | 08/07/2026 | 300.65 K | $11.06 M | 5.18% | 0.60% |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 07/08/2026 | 276.70 K | $10.18 M | 50.78% | 0.55% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 08/14/2026 | 252.40 K | $9.29 M | -36.18% | 0.50% |
| J. GOLDMAN & CO LP | 08/14/2026 | 212.78 K | $7.83 M | -77.34% | 0.42% |
| PRIVIUM FUND MANAGEMENT B.V. | 08/07/2026 | 210.00 K | $7.73 M | -11.81% | 0.42% |
| FMR LLC | 08/13/2026 | 197.10 K | $7.25 M | 35.97% | 0.39% |
| SUPERSTRING CAPITAL MANAGEMENT LP | 08/14/2026 | 191.31 K | $7.04 M | -50.61% | 0.38% |
| PARKMAN HEALTHCARE PARTNERS LLC | 08/14/2026 | 174.06 K | $6.41 M | -36.70% | 0.35% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 150.30 K | $5.53 M | 27.37% | 0.30% |
| AQR CAPITAL MANAGEMENT LLC | 08/14/2026 | 149.23 K | $5.49 M | 3.59% | 0.30% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 148.96 K | $5.48 M | -16.27% | 0.30% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 128.37 K | $4.72 M | 45.11% | 0.25% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 128.37 K | $4.72 M | 100.00% | 0.25% |
| UBS GROUP AG | 08/13/2026 | 121.46 K | $4.47 M | -23.92% | 0.24% |
| ELMIND CAPITAL, LP | 08/14/2026 | 120.00 K | $4.42 M | -45.45% | 0.24% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2026 | 115.36 K | $4.25 M | 15.11% | 0.23% |
| BANK OF NEW YORK MELLON CORP | 08/06/2026 | 113.03 K | $4.16 M | 14.24% | 0.22% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 08/14/2026 | 111.14 K | $4.09 M | -51.81% | 0.22% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 111.00 K | $4.08 M | -4.15% | 0.22% |
| AISLING CAPITAL MANAGEMENT LP | 08/13/2026 | 108.00 K | $3.97 M | 0.00% | 0.21% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 106.69 K | $3.93 M | -71.23% | 0.21% |
| TIDAL INVESTMENTS LLC | 08/13/2026 | 101.84 K | $3.75 M | -1.08% | 0.20% |
| ARK INVESTMENT MANAGEMENT LLC | 08/14/2026 | 101.51 K | $3.74 M | -12.15% | 0.20% |
UroGen Pharma Ltd institutional Ownership - FAQ's
During the previous two years, 226 institutional investors and hedge funds held shares of UroGen Pharma Ltd. The most heavily invested institutionals were:
Privium Fund Management B.V.: 107,915
OAK RIDGE INVESTMENTS LLC: 74,743
TRUIST FINANCIAL CORP: 72,303
CITIGROUP INC: 17,973
CenterBook Partners LP: 15,800
Creative Planning: 14,714
84.47% of UroGen Pharma Ltd stock is owned by institutional investors.
Institutional investors have bought a total of 50.17 M shares in the last 24 months. This purchase volume represents approximately $998.91 M in transactions.